Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-cash Items: 2018-2025

Historic Non-cash Items for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to $6.6 million.

  • Bicycle Therapeutics' Non-cash Items rose 30.00% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 30.00%. This contributed to the annual value of $5.4 million for FY2024, which is 17.48% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Non-cash Items stood at $6.6 million, which was up 149.07% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Non-cash Items ranged from a high of $207.0 million in Q4 2021 and a low of $2.0 million during Q1 2021.
  • Over the past 3 years, Bicycle Therapeutics' median Non-cash Items value was $5.4 million (recorded in 2024), while the average stood at $15.2 million.
  • As far as peak fluctuations go, Bicycle Therapeutics' Non-cash Items tumbled by 93.46% in 2021, and later skyrocketed by 832.56% in 2023.
  • Over the past 5 years, Bicycle Therapeutics' Non-cash Items (Quarterly) stood at $207.0 million in 2021, then plummeted by 65.70% to $71.0 million in 2022, then crashed by 69.13% to $21.9 million in 2023, then tumbled by 75.55% to $5.4 million in 2024, then rose by 30.00% to $6.6 million in 2025.
  • Its last three reported values are $6.6 million in Q3 2025, $2.7 million for Q2 2025, and $3.3 million during Q1 2025.